These Tregs make up approximately 10-4% of CD5+ T cells in circulation [119], and their administration after regulatory T-cell infusion significantly mitigated tPA-induced cerebral haemorrhage in both suture and embolization models [120]. The gene discussed is PLAT; the disease is hemorrhage.